Variability in response to EGFR inhibition and expression of EGFR in HNSCC also suggests that EGFR-independent pathways, such as the m-TOR dependent Akt pathway, often concomitantly contribute to the local progression of HNSCC prior to and following its metastatic spread [14]. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.